Serum paraoxonase, TAS, TOS and ceruloplasmin in brucellosis.

UNLABELLED It is possible that brucellosis may be related to increase free radical production and antioxidant depletion. Thus, in the present study we aimed to evaluate the oxidative status in patient with brucellosis and healthy controls. METHODS This study includes the patients with brucellosis diagnosed by clinical findings and positive agglutination titer. The paraoxonase, ceruloplasmin, total antioxidant capacity and total oxidant status values were measured from the samples taken. The oxidative stress index value was calculated through the total antioxidant capacity and total oxidant status values. RESULTS A total number of 93 people, 40 women (43%) and 53 men (57%) were included to the study. The levels of ceruloplasmin were found higher in patients when compared to the control group (p < 0.001). The total antioxidant capacity level was found significantly higher in the patients group when compared to the control group (p < 0.001). The oxidative stress index value was significantly lower in the patients group when compared to the control group (p < 0.001). The paraoxonase-1 level was not different in control and patient groups (p = 0.077). CONCLUSIONS Brucellosis is an infection that is frequently seen in Mediterranean countries. This infection breaks the oxidant and antioxidant balance. In this disease, oxidant-antioxidant system indicators such as ceruloplasmin, total antioxidant capacity, total oxidant status and oxidative stress index can be used for showing the role of the brucella infection and for the monitoring of the treatment results.

[1]  D. Stevens,et al.  Inflammatory marker profiles in an avian experimental model of aspergillosis. , 2013, Medical mycology.

[2]  N. Aksoy,et al.  Evaluation of ceruloplasmin levels in patients with pulmonary cystic echinococcus. , 2013, La Clinica terapeutica.

[3]  H. Hasan,et al.  Salivary Ceruloplasmin Ferroxidase & Oxidase Activities in Celiac Patients , 2012, International journal of biomedical science : IJBS.

[4]  M. Usta,et al.  Oxidant and antioxidant parameters in patients with Brucella canis. , 2012, Clinical biochemistry.

[5]  T. Krechler,et al.  Paraoxonase-1 (PON1) status in pancreatic cancer: relation to clinical parameters. , 2012, Folia biologica.

[6]  G. Mermut,et al.  Clinical, Diagnostic and Therapeutic Approaches to Complications of Brucellosis: An Experience of 12 Years , 2011, Medical Principles and Practice.

[7]  İ. Koruk,et al.  Decreasing oxidative stress in response to treatment in patients with brucellosis: could it be used to monitor treatment? , 2011, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[8]  A. Eker,et al.  A patient with brucellar cervical spondylodiscitis complicated by epidural abscess , 2011, Journal of Clinical Neuroscience.

[9]  E. Levy,et al.  The three-gene paraoxonase family: physiologic roles, actions and regulation. , 2011, Atherosclerosis.

[10]  S. Boyle,et al.  Brucellosis: a re-emerging zoonosis. , 2010, Veterinary microbiology.

[11]  M. Elisaf,et al.  Persistence of an atherogenic lipid profile after treatment of acute infection with brucella , 2009, Journal of Lipid Research.

[12]  O. Erel,et al.  Evaluation of oxidative status in patients with brucellosis. , 2009, The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases.

[13]  K. Konstantopoulos,et al.  Serum ceruloplasmin as a marker in prostate cancer. , 2007, Minerva urologica e nefrologica = The Italian journal of urology and nephrology.

[14]  L. V. Van Gaal,et al.  Impact of diabetes mellitus on the relationships between iron‐, inflammatory‐ and oxidative stress status , 2006, Diabetes/metabolism research and reviews.

[15]  O. Erel,et al.  A new automated colorimetric method for measuring total oxidant status. , 2005, Clinical biochemistry.

[16]  H. Çelik,et al.  Increased DNA damage and oxidative stress in patients with cutaneous leishmaniasis. , 2005, Mutation research.

[17]  O. Erel,et al.  A novel automated method to measure total antioxidant response against potent free radical reactions. , 2004, Clinical biochemistry.

[18]  J. Gitlin,et al.  Ceruloplasmin metabolism and function. , 2002, Annual review of nutrition.

[19]  M. Mańczak,et al.  Oxidase activity of ceruloplasmin and concentrations of copper and zinc in serum of cancer patients. , 2001, Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements.

[20]  J. Gitlin Transcriptional regulation of ceruloplasmin gene expression during inflammation. , 1988, The Journal of biological chemistry.

[21]  J. Lunec,et al.  The behaviour of caeruloplasmin in stored human extracellular fluids in relation to ferroxidase II activity, lipid peroxidation and phenanthroline-detectable copper. , 1985, The Biochemical journal.

[22]  L. Fernandez-Herlihy,et al.  Human brucellosis. , 1959, The Lahey Clinic bulletin.